CSL 0.67% $288.21 csl limited

Goodbye to $100?, page-19

  1. 5,147 Posts.
    lightbulb Created with Sketch. 60
    More from the review article

    "The rationale for flu immunization as a national health priority is that influenza is a disease with serious complications, such as pneumonia, hospitalization, and death.[5,13,28] If the reason for influenza vaccination is that flu is such a serious disease, then the relevant outcomes are whether vaccination improves morbidity and mortality from flu. However, after decades of vaccine use, it is hard to detect any public health impact. This is in stark contrast to other routine vaccinations, such as polio andHaemophilus influenzae type b, where introduction of the vaccine led to obvious decline of the disease.

    We are pediatricians, and we believe in childhood immunizations. Many vaccines have provided immense public health value. We simply question whether the policy of routine influenza vaccination has outpaced the data supporting its use.
    Influenza vaccination now supersedes many other priorities of public health (such as obesity, illiteracy, and high school dropout), and we question whether so much time, effort, and money should be dedicated to flu vaccination while these other national healthcare priorities remain on the back burner."
 
watchlist Created with Sketch. Add CSL (ASX) to my watchlist
(20min delay)
Last
$288.21
Change
1.930(0.67%)
Mkt cap ! $139.5B
Open High Low Value Volume
$286.56 $290.44 $285.15 $147.0M 510.0K

Buyers (Bids)

No. Vol. Price($)
1 173 $288.12
 

Sellers (Offers)

Price($) Vol. No.
$288.24 935 1
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.